
BREAKING: Breakthrough as First Malaria Treatment for Babies Approved, Roll Out in Africa Soon
A significant breakthrough in the search for a suitable malaria treatment for newborns and babies has recorded with the drug known as Coartem Baby or Riamet Baby, developed by Novartis in collaboration with the Medicines for Malaria Venture (MMV), a Swiss-based not-for-profit organisation. MMV was initially backed by the British, Swiss and Dutch Governments, as…